Matthew W. Foehr, Director at Viking Therapeutics, Inc. (VKTX), sold 32,000 shares at $35.11 ($1.1M) on 2026-01-02, disclosed to the SEC on 2026-01-05.
Open-market sale of $1.1M VKTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.11 | 16,000 | $562K | 50.0% |
| 2 | $35.11 | 16,000 | $562K | 50.0% |
| Total | $35.11 avg | 32,000 | $1.1M | 100% |
| Filing → |
| OABI | SELL | 2026-02-17 | $35K | — | Filing → |
| OABI | SELL | 2025-12-09 | $27K | — | Filing → |
| OABI | SELL | 2025-04-07 | $39K | — | Filing → |